Site of First Recurrence: Gastric Cancer Trial Data from 2017-2021

13 patients from 2 institutions were enrolled in a single-arm Phase II trial evaluating extensive intraoperative peritoneal lavage for gastric cancer. The dataset likely contains relapse-free survival, overall survival, recurrence site, and adverse event outcomes. Gen Tsujio published the data on figshare under a CC-BY-4.0 license.

Use Cases

• Analyze relapse-free survival outcomes based on cytology status mentioned in the description
• Compare peritoneal recurrence rates between CY0 and CY1 patient groups
• Evaluate postoperative adverse events associated with the surgical procedure
• Assess the impact of extensive intraoperative peritoneal lavage on overall survival

Strengths

• Data originates from a multi-institutional exploratory Phase II clinical trial
• Includes median 3-year relapse-free survival and peritoneal relapse-free survival metrics
• Published under an open CC-BY-4.0 license

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• The trial was closed early due to slow accrual, resulting in a small cohort of 13 patients

Provenance

Source

figshare, author Gen Tsujio

Collection Method

Data collected from a single-arm, multi-institutional exploratory Phase II trial

Time Range

2017 to 2021

Freshness

Last updated 2026-04-17 17:47:00; freshness should be verified